Lawyers Compete To Represent Zetia Buyers In Antitrust Case

By Chuck Stanley (July 30, 2018, 8:57 PM EDT) -- More than a half-dozen law firms representing buyers of the cholesterol drug Zetia launched competing bids Friday to act as interim counsel for end payors for the drug in an antitrust MDL accusing Merck & Co. of orchestrating a pay-for-delay scheme to keep a generic version of the drug off the market....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!